Form D · Other Health Care
Oncobiomix Inc.
San Antonio, TX · CIK 0001998501
Offering snapshot reported Sep 16, 2026 · SEC filing
- Reported sold
- $100K Offering amount: $2.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 14, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 16, 2026 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Sep 2, 2025 | Amendment | $500,000 | No comparison | 12 | SEC filing |
| Sep 2, 2025 | Amendment | $500,000 | No comparison | 12 | SEC filing |
| Sep 3, 2024 | Amendment | $480,000 | $330,000vs Nov 6, 2023 | 11 | SEC filing |
| Nov 6, 2023 | Initial | $150,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-597743
Source: Form D, filed Sep 16, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Andre Liss | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3463 Magic Drive Suite T7
San Antonio, TX, 78229
San Antonio, TX, 78229